Millipore Sigma Vibrant Logo

569397 Staurosporine, Streptomyces sp.

Panorama geral

Replacement Information

Tabela com principais espec.

CAS #Empirical Formula
62996-74-1C₂₈H₂₆N₄O₃

Preço e Disponibilidade

Número de catálogo DisponibilidadeEmbalagem Qtde/Emb. Preço Quantidade
569397-100UG
Verificando a disponibilidade...
Disponibilidade limitada
Disponibilidade limitada
Insira quantidade 
Descontinuado
Quantidades limitadas disponíveis
Disponibilidade a ser confirmada
    Restante: será informado
      Restante: será informado
      Vai informar
      Contatar o serviço de atendimento ao cliente
      Contact Customer Service

      Ampola plástica 100 μg
      Recuperando preço...
      O preço não pôde ser recuperado
      Quantidade mínima necessária para ser múltipla de
      Maximum Quantity is
      Após finalização do pedido Mais informações
      Você salvou ()
       
      Solicitar preço
      569397-250UG
      Verificando a disponibilidade...
      Disponibilidade limitada
Disponibilidade limitada
      Insira quantidade 
      Descontinuado
      Quantidades limitadas disponíveis
      Disponibilidade a ser confirmada
        Restante: será informado
          Restante: será informado
          Vai informar
          Contatar o serviço de atendimento ao cliente
          Contact Customer Service

          Ampola plástica 250 μg
          Recuperando preço...
          O preço não pôde ser recuperado
          Quantidade mínima necessária para ser múltipla de
          Maximum Quantity is
          Após finalização do pedido Mais informações
          Você salvou ()
           
          Solicitar preço
          Description
          OverviewA potent, cell-permeable, reversible, ATP-competitive and broad spectrum inhibitor of protein kinases. Inhibits protein kinase A (IC50 = 7 nM), CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase C (IC50 = 700 pM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint. A 1 mM (100 µg/214 µl) solution of Staurosporine (Cat. No. 569396) in DMSO is also available.
          Catalogue Number569397
          Brand Family Calbiochem®
          SynonymsPKA Inhibitor II, MLCK Inhibitor I
          References
          ReferencesCouldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
          Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
          Bruno, S., et al. 1992. Cancer Res. 52, 470.
          Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
          Vitale, M.L., et al. 1992. Neuroscience 51, 463.
          Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
          Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.
          Product Information
          CAS number62996-74-1
          ATP CompetitiveY
          FormWhite to pale yellow solid
          Hill FormulaC₂₈H₂₆N₄O₃
          Chemical formulaC₂₈H₂₆N₄O₃
          ReversibleY
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary TargetPKA
          Primary Target IC<sub>50</sub>7 nM, 20 nM, 1.3 nM, 700 pM, and 8.5 nM against protein kinase A , CaM kinase, myosin light chain kinase, protein kinase C, and protein kinase G, respectively
          Purity≥99% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Número de catálogo GTIN
          569397-100UG 07790788057855
          569397-250UG 04055977190496

          Documentation

          Staurosporine, Streptomyces sp. MSDS

          Título

          Ficha de Segurança de Produtos (MSDS) 

          Staurosporine, Streptomyces sp. Certificados de análise

          TítuloNúmero do lote
          569397

          Referências

          Visão geral de referência
          Couldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
          Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
          Bruno, S., et al. 1992. Cancer Res. 52, 470.
          Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
          Vitale, M.L., et al. 1992. Neuroscience 51, 463.
          Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
          Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.

          Brochura

          Título
          Caspases and other Apoptosis Related Tools Brochure
          Protein Kinase Assay and Detection Kits Brochure
          Tools and Tips for Analyzing Apoptosis

          Citações

          Título
        • Joao B. Oliveira, et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Procedings of the National Academy of Science 104, 8953-8958.
        • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
        • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
        • Ficha de dados

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision17-July-2014 JSW
          SynonymsPKA Inhibitor II, MLCK Inhibitor I
          DescriptionA potent, cell-permeable, reversible, ATP-competitive and broad spectrum inhibitor of protein kinases. Inhibits CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase A (IC50 = 7 nM), protein kinase C (IC50 = 0.7 nM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint.
          FormWhite to pale yellow solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number62996-74-1
          Chemical formulaC₂₈H₂₆N₄O₃
          Structure formulaStructure formula
          Purity≥99% by HPLC
          SolubilityDMSO (5 mg/ml). Further dilute with aqueous buffers just prior to use.
          Storage Protect from light
          +2°C to +8°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
          Toxicity Standard Handling
          ReferencesCouldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
          Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
          Bruno, S., et al. 1992. Cancer Res. 52, 470.
          Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
          Vitale, M.L., et al. 1992. Neuroscience 51, 463.
          Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
          Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.
          Citation
        • Joao B. Oliveira, et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Procedings of the National Academy of Science 104, 8953-8958.
        • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
        • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
        • Produtos e aplicações relacionadas

          Categorias

          Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase C (PKC) Inhibitors
          Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase A (PKA; cAMP-Dependent Protein Kinase) Inhibitors
          Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase G (PKG; cGMP-Dependent Protein Kinase) Inhibitors